Aurora Cannabis (NYSE: ACB) (TSX: ACB) has named Dr. Shane Morris as chief product officer and André Jérôme as chief integration officer.

Morris previously worked as senior vice president of product development and regulatory affairs, while Jérôme was senior vice president of business integrations.

The appointments are effective immediately.

Morris joined Aurora in January 2018 to lead the company’s product development and regulatory affairs initiatives. He has led the development, regulatory oversight and market introduction for several of the company’s cannabis products, including Aurora’s Oral Mist, Oral Dissolve Strips, and Aurora Cloud, the first-ever vape-ready oil cartridge to be introduced under Health Canada regulations. He holds a Ph.D. in plant science and policy from the National University of Ireland.

In his new role, Morris will be responsible for the company’s product development for the Canadian and international markets.

Jérôme joined Aurora in February 2018 through the acquisition of H2 Biopharma which now operates as the company’s Aurora Eau facility in Lachute, Quebec. Initially responsible for the integration of Aurora’s acquisitions as well as the identification of synergies across existing subsidiaries and joint venture partners, Jérôme’s role has expanded over the last 18 months to include global security, health, safety & environment, and oversight for a number of subsidiaries.

As chief integration officer, André will oversee all current and future integrations with a focus on value generation to support the company’s expansion strategy. He has led the successful integration of many of Aurora’s largest business assets including CanniMed Therapeutics, MedReleaf, Whistler Cannabis, and Anandia Laboratories.